HLA-A and breast carcinoma: Further analysis of four HLA-A*02 healthy individuals demonstrated the immunogenic potential of two individual peptides, P11 (LDHC41−55) and P73 (LDHC288−303), and the functional activity of the respective-primed T cells against breast cancer cell lines.